Nuveen Asset Management, LLC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 37 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$37,464
-62.0%
14,8080.0%0.00%
Q2 2023$98,621
+8513.2%
14,808
-75.9%
0.00%
Q1 2023$1,145
-73.9%
61,340
-70.0%
0.00%
-100.0%
Q4 2022$4,390
-99.8%
204,407
-6.1%
0.00%
+100.0%
Q3 2022$2,572,000
+75.1%
217,624
+95.5%
0.00%0.0%
Q2 2022$1,469,000
+53.3%
111,310
+95.3%
0.00%
Q1 2022$958,000
-21.7%
57,006
-5.3%
0.00%
Q4 2021$1,224,000
-14.3%
60,221
+29.4%
0.00%
Q3 2021$1,428,000
-12.0%
46,527
-16.6%
0.00%
Q2 2021$1,622,000
-29.8%
55,802
+4.3%
0.00%
-100.0%
Q1 2021$2,309,000
-9.3%
53,494
-2.9%
0.00%0.0%
Q4 2020$2,545,000
-37.6%
55,070
-41.5%
0.00%
-50.0%
Q3 2020$4,080,000
-50.3%
94,095
-39.3%
0.00%
-33.3%
Q2 2020$8,217,000
+138.5%
155,007
+0.6%
0.00%
+50.0%
Q1 2020$3,445,000
+2108.3%
154,146
+1341.4%
0.00%
Q4 2019$156,000
+108.0%
10,6940.0%0.00%
Q3 2019$75,000
-35.9%
10,6940.0%0.00%
Q2 2019$117,00010,6940.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders